| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $457.5M | $405.9M | $333.6M |
| YoY Revenue Growth % | +12.7% | +21.7% | — |
| Gross Profit | $354.9M | $314.4M | — |
| Gross Margin % | 77.6% | 77.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$43.5M | -$60.4M | -$69.3M |
| Operating Margin % | -9.5% | -14.9% | -20.8% |
| Net Income (GAAP) | -$43.3M | -$62.0M | -$66.4M |
| EBITDA (Normalized) | -$40.2M | -$58.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $43.4M | $26.3M | $6.5M |
| Capital Expenditures (CapEx) | $4.1M | $3.0M | — |
| Free Cash Flow (FCF) | $39.3M | $23.4M | $6.5M |
| FCF Margin % | 8.6% | 5.8% | 1.9% |
| Return on Invested Capital (ROIC %) | -31.7% | -45.0% | — |
| Cash & Short-Term Equivalents | $95.3M | $86.4M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $203.4M | $166.6M | — |